|
Transplantation
Citations 301-310 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation
- Philippe Armand, Haesook T. Kim, Corey S. Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer, and Joseph H. Antin
Blood 2007; 109: 4586-4588.
[Abstract]
[Full text]
[PDF]
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
- Jan J. Cornelissen, Wim L. J. van Putten, Leo F. Verdonck, Matthias Theobald, Emanuel Jacky, Simon M. G. Daenen, Marinus van Marwijk Kooy, Pierre Wijermans, Harry Schouten, Peter C. Huijgens, Hans van der Lelie, Martin Fey, Augustin Ferrant, Johan Maertens, Alois Gratwohl, and Bob Lowenberg
Blood 2007; 109: 3658-3666.
[Abstract]
[Full text]
[PDF]
Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease
- Moniek A. de Witte, Mireille Toebes, Ji-Ying Song, Monika C. Wolkers, and Ton N. M. Schumacher
Blood 2007; 109: 3830-3838.
[Abstract]
[Full text]
[PDF]
HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation
- Judith A. Wade, Carolyn Katovich Hurley, Steven K. Takemoto, John Thompson, Stella M. Davies, Thomas C. Fuller, Glenn Rodey, Dennis L. Confer, Harriet Noreen, Michael Haagenson, Fangyu Kan, John Klein, Mary Eapen, Stephen Spellman, and Craig Kollman
Blood 2007; 109: 4064-4070.
[Abstract]
[Full text]
[PDF]
New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses
- Dong Zhang, Wei Yang, Nicolas Degauque, Yan Tian, Allison Mikita, and Xin Xiao Zheng
Blood 2007; 109: 4071-4079.
[Abstract]
[Full text]
[PDF]
Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation
- Mathias M. Hauri-Hohl, Marcel P. Keller, Jason Gill, Katrin Hafen, Esther Pachlatko, Thomas Boulay, Annick Peter, Georg A. Holländer, and Werner Krenger
Blood 2007; 109: 4080-4088.
[Abstract]
[Full text]
[PDF]
Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene
- Cornelis A. M. van Bergen, Michel G. D. Kester, Inge Jedema, Mirjam H. M. Heemskerk, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, W. A. Erik Marijt, Arnoud H. de Ru, M. Ron Schaafsma, Roel Willemze, Peter A. van Veelen, and J. H. Frederik Falkenburg
Blood 2007; 109: 4089-4096.
[Abstract]
[Full text]
[PDF]
Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease
- Yanhui Xu, Andrew S. Flies, Dallas B. Flies, Gefeng Zhu, Sudarshan Anand, Sarah J. Flies, Haiying Xu, Robert A. Anders, Wayne W. Hancock, Lieping Chen, and Koji Tamada
Blood 2007; 109: 4097-4104.
[Abstract]
[Full text]
[PDF]
Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors
- Andreas Lundqvist, J. Philip McCoy, Leigh Samsel, and Richard Childs
Blood 2007; 109: 3603-3606.
[Abstract]
[Full text]
[PDF]
Hyperacute GVHD: risk factors, outcomes, and clinical implications
- Rima M. Saliba, Marcos de Lima, Sergio Giralt, Borje Andersson, Issa F. Khouri, Chitra Hosing, Shubhra Ghosh, Joyce Neumann, Yvonne Hsu, Jorge De Jesus, Muzaffar H. Qazilbash, Richard E. Champlin, and Daniel R. Couriel
Blood 2007; 109: 2751-2758.
[Abstract]
[Full text]
[PDF]
|
|
